Xenos Bio

Xenos Bio is developing a computational platform that uses physics-based algorithms integrated with machine learning to predict protein-protein interactions and identify binding motifs within functional protein domains.

Its software is deployed for rational peptide library construction, delivering enhanced hit identification rates over conventional screening approaches.

The company also has internal lead candidates in the cardiometabolic space and offers its platform as a managed service to biotech and biopharma partners.